2α-Functionalization of 1α,25-dihydroxyvitamin D3 (active vitamin D3) A-ring enhances binding affinity for the vitamin D receptor (VDR) and prolongs the half-life in target cells due to gaining resistance to CYP24A1-dependant metabolism. The wide variety of modified A-ring precursor enynes for Trost coupling with CD-ring bromoolefin were synthesized from d-glucose. The A-ring modification provided potent, selective biological activities without calcemic side-effects in vivo; for example, 2α-(3-hydroxypropyl)-19-nor-1α,25-dihydroxyvitamin D3 (MART-10) exhibits potent antitumor activity (0.3µg/kg/d, twice/week for 3 weeks) in nude mice inoculated with BxpC-3 cancer cells, 2α-[2-(tetrazol-2-yl)ethyl]-1α,25-dihydroxyvitamin D3 (AH-1) shows better bone-forming effects (0.02µg/kg/d, 5d/week for 4 weeks) in ovariectomized (OVX) rats as an osteoporosis model than natural active vitamin D3, and NS-74c exhibits potent VDR-antagonistic activity (IC50 7.4pM) in HL-60 culture cells. The A-ring modification was also applicable to the synthesis of stable 14-epi-19-nortachysterols, and their novel VDR binding mode was confirmed by X-ray co-crystallographic analysis. 25-Hydroxyvitamin D3 has two independent target molecules: VDR and a sterol regulatory element-binding protein (SREBP)/SREBP cleavage-activating protein (SCAP) complex, and 25-hydroxyvitamin D3 shows SREBP/SCAP inhibitory activity. The VDR-silent vitamin D analog KK-052 with selective SREBP/SCAP inhibitory activity in vivo was developed. A chemical library of side-chain fluorinated vitamin D analogs is currently under construction, and some analogs have shown potent anti-inflammatory activity and therapeutic effects on psoriasis model mice.
This study investigates the influence of needleless versus needle-based electrospinning methods on the fiber diameter of polyamide 6 (PA6) nanofibers under comparable conditions, with an emphasis on potential pharmaceutical applications. Additionally, it examines how varying solvent systems impact fiber diameter specifically in needleless electrospinning. In this study, it was found that fibers produced by the needleless method were thicker compared to those produced by the needle-based method, a trend attributable to the specific solution characteristics and parameter settings unique to this study. Notably, a 2 : 1 acetic acid : formic acid solvent mixture yielded the largest fiber diameters among the solvent systems assessed for needleless electrospinning. These results underscore the potential of PA6 nanofibers in pharmaceutical applications, suggesting that further optimization of electrospinning conditions could enhance their suitability. The study also discusses the implications of scale-up production using needleless technology, highlighting its viability for industrial applications over single-needle electrospinning.
This study compares needleless and needle-based electrospinning methods for producing polyamide 6 (PA6) nanofibers, emphasizing fiber diameter and solvent effects. The needleless method produced thicker fibers, with the largest diameters obtained using a 2:1 acetic acid: formic acid solvent system. While the needle-based method provides better control over fiber morphology, the needleless technique enables higher production rates, making it more viable for industrial applications. The findings highlight the need for further optimization to enhance PA6 nanofibers’ suitability for pharmaceutical and biomedical uses, including drug delivery and wound dressing applications.
Osteoporosis is caused by an imbalance between bone resorption and formation, which decreases bone mass and strength and increases the risk of fracture. Therefore, osteoporosis is treated with oral resorption inhibitors, such as bisphosphonates, and parenteral osteogenic drugs, including parathyroid hormone and antisclerostin antibodies. However, orally active osteogenic drugs have not yet been developed. In the present study, to find novel candidates for oral osteogenic drugs, various benzofuran derivatives were synthesized and their effects on osteoblast differentiation were examined in mouse mesenchymal stem cells (ST2 cells). Among the compounds tested, 3-{4-[2-(2-isopropoxyethoxy)ethoxy]phenyl}benzofuran-5-carboxamide (23d) exhibited potent osteoblast differentiation-promoting activity, estimated as EC200 for increasing alkaline phosphatase activity, and good oral absorption in female rats, resulting in high Cmax/EC200. Dual-energy X-ray absorptiometry scanning revealed that 23d at 10 mg/kg/d for 8 weeks increased femoral bone mineral density in ovariectomized rats with an elevation in plasma bone-type alkaline phosphatase activity, and micro-computed tomography showed that it increased bone volume, mineral contents, and strength in femoral diaphysis cortical, but not trabecular bone during the experiment period. 23d potently inhibited cyclin-dependent kinase 8 (CDK8) activity, suggesting that its osteoblastogenic activity is mediated by the suppression of CDK8, as previously reported for diphenylether derivatives. In conclusion, the structure–activity relationships of novel benzofuran derivatives were clarified and 3,5-disubstituted benzofuran was identified as a useful scaffold for orally active osteogenic compounds. Compound 23d exhibited potent osteoblastogenic activity through CDK8 inhibition and osteogenic effects in ovariectomized rats, indicating its potential as an orally active anti-osteoporotic drug.
[Highlighted Paper selected by Editor-in-Chief]
The
authors synthesized a novel series of 3,5-disubstituted benzofuran derivatives with
osteoblastogenic activities and investigated their structure–activity
relationships. Compound 23d, which contained a substituent with a tetrahydropyranyl
group used in previously reported diphenylether derivatives, exhibited lower
activity, but higher oral absorbability, resulting in similar osteogenic
effects to diphenylether derivatives in ovariectomized female rats. These
effects were mediated by the inhibition of cyclin-dependent kinase 8. Therefore,
3,5-disubstituted benzofuran is a useful scaffold for orally active osteogenic
agents, and 23d is a potential candidate for a novel anti-osteoporotic drug.
In the present study, the stability of a supersaturated solution of indomethacin (IM) was evaluated in hydrophobically modified hydroxypropylmethylcellulose (HM-HPMC) solutions, with and without parent cyclodextrins (CDs). A highly supersaturated state of IM was maintained in the HM-HPMC solution and was further stabilized by the addition of α-CD and β-CD. Notably, the highest level of supersaturation was achieved in HM-HPMC/α-CD solution, which maintained a high concentration of IM for up to 120 h. IM concentrations in these solutions exceeded the amorphous solubility, indicating that phase separation had occurred. To explore this phase separation, Nile Red, a fluorescent probe sensitive to hydrophobic environments, was added to the supersaturated solutions. A higher fluorescence intensity was observed in the HM-HPMC/α-CD solution compared with the HM-HPMC solution, indicating a significant formation of colloidal amorphous aggregates in the supersaturated solution. Cryogenic transmission electron microscopy (Cryo TEM) analysis confirmed the presence of these aggregates, which appeared irregularly shaped. These findings suggest that the combination of HM-HPMC and α-CD effectively stabilized the colloidal amorphous aggregates in the IM supersaturated solution. The addition of α-CD facilitated the dissociation of HM-HPMC into smaller particles, increasing the number of hydrophobic stearyl moieties available for interactions with amorphous IM aggregates, thereby enhancing the stability of the supersaturated state. The combination of HM-HPMC and α-CD offers a promising approach to improving the oral bioavailability of drugs with poor water solubility.
Amorphous solid dispersions (ASDs) have garnered significant interest for enhancing the oral bioavailability of poorly water-soluble drugs by generating supersaturated drug concentrations. The stabilization of drug supersaturation critically depends on the structure–property–performance relationships of polymers employed. However, the development of such polymers using economical and practical methods remains challenging. In this study, the authors demonstrated that a highly supersaturated state of indomethacin (IM) can be maintained through a combination of hydrophobically modified hydroxypropylmethylcellulose (HM-HPMC) and α-cyclodextrin (α-CD). α-CD alters the association state of HM-HPMC by forming inclusion complexes with its stearyl moieties, thereby enhancing the stability of IM supersaturation. The combined use of HM-HPMC and α-CD represents a promising and simple strategy for modulating polymer properties and improving the oral bioavailability of poorly water-soluble drugs in ASD formulations.
A method for preparing the fused cyclohexane and pyrrolidine portion of the strychnos skeleton has been developed using domino intermolecular and intramolecular SN2 cyclization. Using this method, the formation of pyrrolidine proceeded smoothly with good yield without the E2 elimination product. This reaction condition is effective for synthesizing the fused cyclohexane and pyrrolidine portion of the strychnos skeleton.
Strychnos alkaloids, represented by strychnine, have a fused 5-6-6 ring system containing a nitrogen atom and an indoline portion known as the strychnos skeleton. In this manuscript, the authors describe the development of an effective method for constructing the fused cyclohexane and pyrrolidine portion of the strychnos skeleton using domino cyclization as a key step. Thus, cyclization precursors that have a tosylate group as a secondary leaving group on the ring were treated with NsNH2 and K2CO3 in DMF to afford fused cyclohexane and pyrrolidine compounds without an E2 elimination product. This reaction is easy to conduct and yields pyrrolidine in good yield.
Optimization of the manufacturing process based on scientific evidence is essential for quality control of active pharmaceutical ingredients. Real-time monitoring can ensure the production of stable quality crystals in the crystallization process. Raman spectroscopy is an attractive tool for pharmaceutical quality evaluation and process analytical technology because of its ability to analyze samples non-destructively and rapidly. In this study, we attempted to monitor the crystal polymorphs of carbamazepine (CBZ I and CBZ III) during the dissolution and crystallization processes using low-frequency Raman spectroscopy, which can reflect differences in lattice vibrations originating from polymorphs in the scattering peaks. Furthermore, using multivariate analysis of the obtained spectra, we attempted to develop a model that enables the quantification of each polymorph. A partial least squares was performed to build the prediction model. The prediction model was built using a set of 33 calibration samples, and an external set of 12 validation samples was used to evaluate the model. The model presents a good prediction capacity. The quantitative results for the solid amount of carbamazepine in suspension calculated using the model during the dissolution and crystallization process showed results that correlated very well with the particle view results. It is suggested that low-frequency Raman spectroscopy can be used as a useful process analytical technology tool.
Crystal polymorph is a key quality attribute of solid state active pharmaceutical ingredients. Authors successfully monitored the crystal polymorphs of carbamazepine during the dissolution and crystallization processes by using low-frequency (LF) Raman spectroscopy. The research is the first application of multivariate analysis on LF Raman spectra to quantitate undissolved crystal polymorphs of carbamazepine during these processes. Calibration models, developed using partial least squares regression, showed good correlation between actual and predicted values, indicating the model’s accuracy in quantitation. It is suggested that LF Raman spectroscopy can serve as a useful tool for process analytical technology.
Density functional theory calculations on the cyclization of di-t-butyl 2-(2-aminophenyl)-2-methyl malonate (1) to t-butyl 3-methyloxindole-3-carboxylate (2) reveal that acetic acid-assisted protonation of the carbonyl oxygen atom reduces the activation Gibbs free energy significantly lower than methanol-assisted pathways. Experimental data confirm that reaction concentration plays a pivotal role in oxindole formation. Experimental results also indicate distinct reaction mechanisms at low and high concentrations. Achieving high enantioselectivity for chiral compound 2 in high-concentration reactions requires discovering a novel chiral acid.